论文部分内容阅读
目的研究观察米非司酮治疗子宫肌瘤的临床治疗效果。方法选取开封市鼓楼区妇幼保健医院于2008年5月至2010年7月收治的54例子宫肌瘤患者,此54例患者均进行保守治疗(口服米非司酮),3个月为1个疗程,均为1个疗程。随后对54例患者随访1年。结果口服米非司酮后54例子宫肌瘤患者均闭经,贫血纠正,血红蛋白也随之上升,围绝经期的患者绝经,肌瘤体积缩小。结论米非司酮治疗子宫肌瘤安全有效,且并发症较少,值得在临床上推广使用。
Objective To observe the clinical efficacy of mifepristone in the treatment of uterine fibroids. Methods 54 cases of uterine leiomyoma treated by MCH Hospital of Gulou District in Kaifeng City from May 2008 to July 2010 were enrolled in this study. All 54 patients were treated conservatively (oral mifepristone) and 1 for 3 months Course of treatment, are a course of treatment. 54 patients were followed up for 1 year. Results After oral mifepristone, 54 cases of uterine fibroids were amenorrhea, anemia correction, hemoglobin also increased, perimenopausal patients with menopause, fibroids shrink. Conclusion Mifepristone treatment of uterine fibroids safe and effective, and fewer complications, it is worth promoting the clinical use.